- Q1 2024 Oncology Institute Inc Earnings Call TranscriptMay 14, 2024$0.9 (+3.54%)Earnings
- Q4 2023 Oncology Institute Inc Earnings Call TranscriptMar 27, 2024$1.84 (+8.88%)Earnings
- Q3 2023 Oncology Institute Inc Earnings Call TranscriptNov 08, 2023$1.84 (+5.75%)Earnings
- Q2 2023 Oncology Institute Inc Earnings Call TranscriptAug 08, 2023$1.01 (+4.12%)Earnings
- Oncology Institute Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q1 2023 Oncology Institute Inc Earnings Call TranscriptMay 10, 2023$0.5 (+4.17%)Earnings
- Q4 2022 Oncology Institute Inc Earnings Call TranscriptMar 09, 2023$1.25 (-11.35%)Earnings
- Q3 2022 Oncology Institute Inc Earnings Call TranscriptNov 09, 2022$3.1 (-4.32%)Earnings
- Q2 2022 Oncology Institute Inc Earnings Call TranscriptAug 09, 2022$6.63 (+0.61%)Earnings
- Oncology Institute Inc at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Q1 2022 Oncology Institute Inc Earnings Call TranscriptMay 11, 2022$5.62 (-14.72%)Earnings
- Q4 2021 Oncology Institute Inc Earnings Call TranscriptMar 10, 2022$4.93 (-14.56%)Earnings
Q3 2023 Oncology Institute Inc Earnings Call Transcript
Good afternoon, and welcome to The Oncology Institute third-quarter 2023 earnings conference call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A. At this time, I would like to turn the conference over to Mark Hueppelsheuser, General Counsel at TOI. Thank you, you may begin.
The press release announcing the Oncology Institute's results for the third-quarter 2023 are available at the investors section of the company's website, theoncologyinstitute.com. A replay of this call will also be available on the company's website after the conclusion of this call.
Before we get started, I would like to remind you of the company's Safe Harbor language. Management may make forward-looking statements, including guidance and underlying assumptions. Forward-looking statements are based on expectations that involve risks and uncertainties that could cause actual results to differ materially. For a further discussion of risks related to our business, see
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)